GLOVER; Nicholas Ronald
Patent Applications and Registrations
Patent applications and USPTO patent grants for GLOVER; Nicholas Ronald.The latest application filed is for "an immunotoxin for treating cancer".
- GLOVER; Nicholas Ronald - Oakville CA
- Glover; Nicholas Ronald - Ontario N/A CA
| Patent | Date |
|---|---|
| An Immunotoxin For Treating Cancer App 20210317203 - ZANGEMEISTER-WITTKE; Uwe ; et al. | 2021-10-14 |
| Immunotoxin For Treating Cancer App 20210040203 - ZANGEMEISTER-WITTKE; Uwe ; et al. | 2021-02-11 |
| Methods for treating cancer using an immunotoxin Grant 10,858,429 - Zangemeister-Wittke , et al. December 8, 2 | 2020-12-08 |
| Methods For Treating Cancer Using An Immunotoxin App 20160199507 - Zangemeister-Wittke; Uwe ; et al. | 2016-07-14 |
| Methods for treating cancer using an immunotoxin Grant 9,259,484 - Zangemeister-Wittke , et al. February 16, 2 | 2016-02-16 |
| Methods for generating and screening fusion protein libraries and uses thereof Grant 9,109,223 - Schwartz Mittelman , et al. August 18, 2 | 2015-08-18 |
| Tumor Specific Antibody App 20150197575 - GLOVER; Nicholas Ronald ; et al. | 2015-07-16 |
| Tumor specific antibody Grant 8,969,540 - Glover , et al. March 3, 2 | 2015-03-03 |
| Methods For Treating Cancer Using An Immunotoxin App 20140178417 - ZANGEMEISTER-WITTKE; Uwe ; et al. | 2014-06-26 |
| Cytotoxins comprising modified bouganin toxin for the treatment of cancer Grant 8,716,234 - Baker , et al. May 6, 2 | 2014-05-06 |
| Cancer specific antibody and cell surface proteins Grant 8,697,075 - Glover , et al. April 15, 2 | 2014-04-15 |
| Methods for treating cancer using an immunotoxin Grant 8,545,840 - Zangemeister-Wittke , et al. October 1, 2 | 2013-10-01 |
| Tumor Specific Antibody App 20130217865 - Glover; Nicholas Ronald ; et al. | 2013-08-22 |
| CD44E tumor specific antibody Grant 8,383,117 - Glover , et al. February 26, 2 | 2013-02-26 |
| Cancer Specific Antibody And Cell Surface Proteins App 20120128723 - CHAHAL; Francina C. ; et al. | 2012-05-24 |
| Cancer associated glucose transporter 8 variant Grant 8,084,576 - Glover , et al. December 27, 2 | 2011-12-27 |
| Cancer Specific Antibody And Cell Surface Proteins App 20100254982 - Glover; Nicholas Ronald ; et al. | 2010-10-07 |
| Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof App 20100254964 - Baker; Matthew ; et al. | 2010-10-07 |
| Methods for Treating Cancer Using an Immunotoxin App 20100249039 - Zangemeister-Wittke; Uwe ; et al. | 2010-09-30 |
| Modified bouganin proteins, cytotoxins and methods and uses thereof Grant 7,750,136 - Baker , et al. July 6, 2 | 2010-07-06 |
| Modified Bouganin Proteins, Cytotoxins And Methods And Uses Thereof App 20080219994 - Baker; Matthew ; et al. | 2008-09-11 |
| Modified bouganin proteins, cytotoxins and methods and uses thereof Grant 7,339,031 - Baker , et al. March 4, 2 | 2008-03-04 |
| Tumor Specific Antibody App 20070292441 - Glover; Nicholas Ronald ; et al. | 2007-12-20 |
| Methods for treating cancer using an immunotoxin App 20070196366 - Zangemeister-Wittke; Uwe ; et al. | 2007-08-23 |
| Treatment of lymphatic metastatic cancerous lesions App 20060210572 - Glover; Nicholas Ronald ; et al. | 2006-09-21 |
| Modified bouganin proteins, cytotoxins and methods and uses thereof App 20050238642 - Baker, Matthew ; et al. | 2005-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 